Stay updated on Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.

Latest updates to the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page
- Check4 days agoChange DetectedThe page’s version/revision label was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study record content.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedA new site revision label 'Revision: v3.5.0' is displayed and the previous 'Revision: v3.4.3' label is removed.SummaryDifference0.0%

- Check47 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded site revision tag v3.4.2 and removed the earlier government-funding notice; this is an administrative update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedA site-wide notice about government funding lapses was added, with guidance to check cc.nih.gov and opm.gov for current status. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.